Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Hologic, Inc. stock logo
HOLX
Hologic
$65.25
+0.4%
$60.00
$51.90
$84.67
$14.54B0.552.37 million shs1.00 million shs
Incyte Corporation stock logo
INCY
Incyte
$68.10
-0.4%
$64.49
$53.56
$83.95
$13.18B0.671.98 million shs914,417 shs
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
$23.99
-0.6%
$23.72
$20.61
$31.57
$23.10B0.76896,269 shs531,854 shs
STERIS plc stock logo
STE
STERIS
$240.03
+0.5%
$236.31
$200.98
$252.79
$23.61B0.94548,017 shs342,501 shs
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Hologic, Inc. stock logo
HOLX
Hologic
0.00%+0.82%+4.69%+5.25%-12.44%
Incyte Corporation stock logo
INCY
Incyte
0.00%-0.13%+4.78%+12.91%+12.78%
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
0.00%+8.37%+4.77%-4.94%-4.21%
STERIS plc stock logo
STE
STERIS
0.00%+1.35%-2.64%+5.06%+8.69%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Hologic, Inc. stock logo
HOLX
Hologic
4.7025 of 5 stars
3.24.00.04.33.03.31.3
Incyte Corporation stock logo
INCY
Incyte
4.3257 of 5 stars
2.13.00.03.12.52.53.1
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
3.7217 of 5 stars
0.05.01.70.03.00.03.1
STERIS plc stock logo
STE
STERIS
4.8979 of 5 stars
3.35.03.33.82.42.51.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Hologic, Inc. stock logo
HOLX
Hologic
2.41
Hold$77.4218.65% Upside
Incyte Corporation stock logo
INCY
Incyte
2.22
Hold$74.539.45% Upside
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
3.00
BuyN/AN/A
STERIS plc stock logo
STE
STERIS
2.63
Moderate Buy$263.839.92% Upside

Current Analyst Ratings Breakdown

Latest HOLX, PHG, STE, and INCY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/23/2025
Incyte Corporation stock logo
INCY
Incyte
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetSector Perform ➝ Sector Perform$67.00
6/16/2025
Incyte Corporation stock logo
INCY
Incyte
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$75.00 ➝ $107.00
6/3/2025
Incyte Corporation stock logo
INCY
Incyte
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
6/3/2025
Incyte Corporation stock logo
INCY
Incyte
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$61.00
5/29/2025
STERIS plc stock logo
STE
STERIS
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageHold$263.00
5/27/2025
Hologic, Inc. stock logo
HOLX
Hologic
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
5/27/2025
Incyte Corporation stock logo
INCY
Incyte
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$72.00 ➝ $73.00
5/19/2025
STERIS plc stock logo
STE
STERIS
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$240.00 ➝ $260.00
5/16/2025
STERIS plc stock logo
STE
STERIS
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform
5/16/2025
STERIS plc stock logo
STE
STERIS
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetMarket Outperform ➝ Market Outperform$265.00 ➝ $280.00
5/15/2025
STERIS plc stock logo
STE
STERIS
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$250.00 ➝ $250.00
(Data available from 6/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Hologic, Inc. stock logo
HOLX
Hologic
$4.03B3.61$5.52 per share11.82$22.09 per share2.95
Incyte Corporation stock logo
INCY
Incyte
$4.24B3.11$0.55 per share123.50$17.90 per share3.80
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
$19.50B1.18$3.08 per share7.79$13.86 per share1.73
STERIS plc stock logo
STE
STERIS
$5.46B4.32$14.33 per share16.75$67.33 per share3.56
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Hologic, Inc. stock logo
HOLX
Hologic
$789.50M$2.3727.5314.122.3813.83%19.71%10.87%8/4/2025 (Estimated)
Incyte Corporation stock logo
INCY
Incyte
$32.62M$0.32212.8210.410.580.48%2.77%1.77%7/29/2025 (Estimated)
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
-$758.55M$0.4355.7912.430.682.11%10.97%4.57%7/29/2025 (Estimated)
STERIS plc stock logo
STE
STERIS
$614.64M$6.2038.7124.17N/A11.26%14.21%9.13%8/5/2025 (Estimated)

Latest HOLX, PHG, STE, and INCY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/14/2025Q4 2025
STERIS plc stock logo
STE
STERIS
$2.59$2.74+$0.15$1.47$1.47 billion$1.48 billion
5/6/2025Q1 2025
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
$0.14$0.27+$0.13$0.09$4.10 billion$4.31 billion
5/1/2025Q2 2025
Hologic, Inc. stock logo
HOLX
Hologic
$1.02$1.03+$0.01-$0.08$1.00 billion$1.01 billion
4/29/2025Q1 2025
Incyte Corporation stock logo
INCY
Incyte
$1.01$1.16+$0.15$0.80$996.17 million$1.05 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Hologic, Inc. stock logo
HOLX
Hologic
N/AN/AN/AN/AN/A
Incyte Corporation stock logo
INCY
Incyte
N/AN/AN/AN/AN/A
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
$0.823.42%N/A190.70%N/A
STERIS plc stock logo
STE
STERIS
$2.280.95%N/A36.77%20 Years

Latest HOLX, PHG, STE, and INCY Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/7/2025
STERIS plc stock logo
STE
STERIS
quarterly$0.571.01%6/10/20256/10/20256/26/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Hologic, Inc. stock logo
HOLX
Hologic
0.54
3.24
2.52
Incyte Corporation stock logo
INCY
Incyte
0.01
2.04
2.00
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
0.60
1.28
0.79
STERIS plc stock logo
STE
STERIS
0.29
1.96
1.39

Institutional Ownership

CompanyInstitutional Ownership
Hologic, Inc. stock logo
HOLX
Hologic
94.73%
Incyte Corporation stock logo
INCY
Incyte
96.97%
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
13.67%
STERIS plc stock logo
STE
STERIS
94.69%

Insider Ownership

CompanyInsider Ownership
Hologic, Inc. stock logo
HOLX
Hologic
1.88%
Incyte Corporation stock logo
INCY
Incyte
17.80%
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
N/A
STERIS plc stock logo
STE
STERIS
1.07%
CompanyEmployeesShares OutstandingFree FloatOptionable
Hologic, Inc. stock logo
HOLX
Hologic
7,063222.85 million218.66 millionOptionable
Incyte Corporation stock logo
INCY
Incyte
2,617193.57 million159.12 millionOptionable
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
78,200962.92 millionN/AOptionable
STERIS plc stock logo
STE
STERIS
16,00098.37 million97.32 millionOptionable

Recent News About These Companies

STERIS plc (STE)
Steris buys Coon Rapids medical offices for $13.1 million

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Hologic stock logo

Hologic NASDAQ:HOLX

$65.25 +0.24 (+0.37%)
As of 03:58 PM Eastern

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and connectivity solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, the company offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Incyte stock logo

Incyte NASDAQ:INCY

$68.10 -0.27 (-0.39%)
As of 03:57 PM Eastern

Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for hematology/oncology, and inflammation and autoimmunity areas in the United States and internationally. The company offers JAKAFI (ruxolitinib) for treatment of intermediate or high-risk myelofibrosis, polycythemia vera, and steroid-refractory acute graft-versus-host disease; MONJUVI (tafasitamab-cxix)/MINJUVI (tafasitamab) for relapsed or refractory diffuse large B-cell lymphoma; PEMAZYRE (pemigatinib), a fibroblast growth factor receptor kinase inhibitor that act as oncogenic drivers in liquid and solid tumor types; ICLUSIG (ponatinib) to treat chronic myeloid leukemia and Philadelphia-chromosome positive acute lymphoblastic leukemia; and ZYNYZ (retifanlimab-dlwr) to treat adults with metastatic or recurrent locally advanced Merkel cell carcinoma, as well as OPZELURA cream for treatment of atopic dermatitis. Its clinical stage products include retifanlimab under Phase 3 clinical trials for squamous cell carcinoma of the anal canal and non-small cell lung cancer; axatilimab, an anti-CSF-1R monoclonal antibody under Phase 2 that is being developed as a therapy for patients with chronic GVHD; INCA033989 to inhibit oncogenesis; INCB160058, which is being developed as a disease-modifying therapeutic; and INCB99280 and INCB99318 for the treatment solid tumors. The company also develops INCB123667, INCA32459, and INCA33890, as well as Ruxolitinib cream, Povorcitinib, and INCA034460. It has collaboration out-license agreements with Novartis and Lilly; in-license agreements with Agenus, Merus, MacroGenics, and Syndax; and collaboration and license agreement with China Medical System Holdings Limited for the development and commercialization of povorcitinib. The company sells its products to specialty, retail, and hospital pharmacies, distributors, and wholesalers. The company was formerly known as Incyte Genomics Inc and changed its name to Incyte Corporation in March 2003. Incyte Corporation was incorporated in 1991 and is headquartered in Wilmington, Delaware.

Koninklijke Philips stock logo

Koninklijke Philips NYSE:PHG

$23.99 -0.15 (-0.62%)
As of 03:58 PM Eastern

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease. In addition, the company offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. Further, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental solutions; and grooming and beauty products and solutions. The company has strategic partnership agreements with TriHealth, Northwell, and Atrium Health. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

STERIS stock logo

STERIS NYSE:STE

$240.03 +1.24 (+0.52%)
As of 03:58 PM Eastern

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and electric-powered dental instruments, infection control products, conscious sedation, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.